AR and prostate carcinoma: Here, we provide evidence that treatment with b-AP15 inhibits the growth of PCa cells and enhances apoptosis of both androgen receptor-dependent and -independent prostate cancer cells, both in vitro and in vivo, associated with induction of caspase activation, ER stress and generation of reactive oxygen species (ROS).